Literature DB >> 19652426

Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome.

Shinji Tamaki1, Motoo Yamauchi, Atsuhiko Fukuoka, Kiyoshi Makinodan, Noriko Koyama, Koichi Tomoda, Masanori Yoshikawa, Hiroshi Kimura.   

Abstract

BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is known to be a risk factor of cardiovascular events. However, the precise mechanism linking the two has not been fully elucidated.
OBJECTIVE: The aim of this study was to investigate the effect of hypoxic stress on the production of tumor necrosis factor (TNF)-alpha, monocyte chemoattractant protein-1 (MCP-1), and matrix metalloproteinase-9 (MMP-9) by monocytes.
METHODS: Thirty-three OSAS patients and 13 healthy control subjects were enrolled. The OSAS patients were classified as mild-to-moderate (13) and severe (20). Venous blood samples were collected before and after sleep as well as after long-term nasal continuous positive airway pressure (CPAP) treatment for the purpose of isolation of monocytes. Peripheral blood monocytes were isolated using standard methods. Monocytes were cultured under lipopolysaccharide stimulation for 24 hours, and TNF-alpha, MCP-1, and MMP-9 in the culture supernatants were determined by ELISA.
RESULTS: In severe patients, the TNF-alpha production by monocytes was significantly elevated as compared to that before sleep (p<0.01). In all OSAS patients, the TNF-alpha production after sleep was significantly correlated with AHI (p<0.01), ODI (p<0.01) and % time in SpO(2)<90% (p<0.05), and inversely correlated with the lowest SpO(2) (p<0.01). The production of MCP-1 and MMP-9 by monocytes was significantly elevated compared to that before sleep in severe patients (p<0.05). The production of these mediators by monocytes was significantly decreased after long-term nasal CPAP treatment (p<0.05).
CONCLUSION: These results indicate that OSAS-induced hypoxic stress activates the production of inflammatory mediators by monocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652426     DOI: 10.2169/internalmedicine.48.2366

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  21 in total

1.  Dim light at night interacts with intermittent hypoxia to alter cognitive and affective responses.

Authors:  Taryn G Aubrecht; Zachary M Weil; Ulysses J Magalang; Randy J Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-08       Impact factor: 3.619

2.  Increased MCP-1 gene expression in monocytes of severe OSA patients and under intermittent hypoxia.

Authors:  Li-Pang Chuang; Ning-Hung Chen; Yuling Lin; Wen-Shan Ko; Jong-Hwei S Pang
Journal:  Sleep Breath       Date:  2015-09-09       Impact factor: 2.816

3.  Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.

Authors:  Jeremy F Weinberger; Charles L Raison; David B Rye; Amy R Montague; Bobbi J Woolwine; Jennifer C Felger; Ebrahim Haroon; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2014-12-18       Impact factor: 7.217

4.  Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.

Authors:  Françoise Stanke-Labesque; Jean-Louis Pépin; Tiphaine de Jouvencel; Claire Arnaud; Jean-Philippe Baguet; Marcelo H Petri; Renaud Tamisier; Jean François Jourdil; Patrick Lévy; Magnus Bäck
Journal:  J Lipid Res       Date:  2012-07-03       Impact factor: 5.922

Review 5.  Chronic cough and OSA: a new association?

Authors:  Krishna M Sundar; Sarah E Daly
Journal:  J Clin Sleep Med       Date:  2011-12-15       Impact factor: 4.062

6.  TST, as a polysomnographic variable, is superior to the apnea hypopnea index for evaluating intermittent hypoxia in severe obstructive sleep apnea.

Authors:  Xiao-Bin Zhang; Hui-Qing Zen; Qi-Chang Lin; Gong-Ping Chen; Li-Da Chen; Hua Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-16       Impact factor: 2.503

7.  Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.

Authors:  Harun Karamanlı; Duygu Özol; K Serife Ugur; Zeki Yıldırım; Ferah Armutçu; Bulent Bozkurt; Ramazan Yigitoglu
Journal:  Sleep Breath       Date:  2012-09-04       Impact factor: 2.816

8.  SERUM LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN MALES WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA.

Authors:  L G Moise; D S Marta; A Raşcu; E Moldoveanu
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

9.  Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis.

Authors:  Aaron Baessler; Rashid Nadeem; Michael Harvey; Essam Madbouly; Amna Younus; Hassan Sajid; Jawed Naseem; Asma Asif; Hasnain Bawaadam
Journal:  J Inflamm (Lond)       Date:  2013-03-22       Impact factor: 4.981

Review 10.  Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.

Authors:  Saif Mashaqi; Heidi M Mansour; Hanan Alameddin; Daniel Combs; Salma Patel; Lauren Estep; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.